NCT00003360View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

August 31, 2000

Conditions
Colorectal Cancer
Interventions
RADIATION

iodine I 131 monoclonal antibody A33

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003360 - Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter